Hyaluronidase in the Prevention of Sclerotherapy-induced Extravasation Necrosis

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.22, Iss.1, 1996-01, pp. : 73-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous Necrosis, Telangiectatic Matting, and Hyperpigmentation following Sclerotherapy Etiology, Prevention, and Treatment

By GOLDMAN MITCHEL P. SADICK NEIL S. WEISS ROBERT A.

Dermatologic Surgery, Vol. 21, Iss. 1, 1995-01 ,pp. : 19-29

Elsevier

Access to resources Recommend Favorite

Redundant function of macrophage inflammatory protein-2 and KC in tumor necrosis factor- -induced extravasation of neutrophils in vivo

By Zhang X.W. Wang Y. Liu Q. Thorlacius H.

European Journal of Pharmacology, Vol. 427, Iss. 3, 2001-09 ,pp. : 277-283

Elsevier

Access to resources Recommend Favorite

Dextrose: Erythema and swelling following drug extravasation, treated with hyaluronidase: case report

Reactions Weekly, Vol. 1, Iss. 1368, 2011-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

The use of dexrazoxane for the prevention of anthracycline extravasation injury

By Hasinoff Brian B

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 217-223

Informa Healthcare

Access to resources Recommend Favorite

Sclerotherapy

By CORNU-THENARD ANDRÉ COTTREAU HERVÉ WEISS ROBERT A.

Dermatologic Surgery, Vol. 21, Iss. 10, 1995-10 ,pp. : 867-870

Elsevier

Access to resources Recommend Favorite